Simplex Trading’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.97M | Sell |
275,600
-370,600
| -57% | -$11.9M | 0.01% | 746 |
|
|
2025
Q4 | $22.7M | Buy |
646,200
+74,100
| +13% | +$2.63M | 0.01% | 511 |
|
|
2025
Q3 | $15M | Buy |
572,100
+230,800
| +68% | +$6.89M | 0.01% | 751 |
|
|
2025
Q2 | $9.04M | Buy |
341,300
+54,600
| +19% | +$1.44M | 0.01% | 955 |
|
|
2025
Q1 | $6.92M | Sell |
286,700
-126,800
| -31% | -$4.01M | ﹤0.01% | 1102 |
|
|
2024
Q4 | $16.6M | Sell |
413,500
-160,200
| -28% | -$9.13M | 0.01% | 731 |
|
|
2024
Q3 | $36.3M | Buy |
573,700
+96,300
| +20% | +$5.65M | 0.02% | 394 |
|
|
2024
Q2 | $25.3M | Sell |
477,400
-25,100
| -5% | -$1.65M | 0.02% | 524 |
|
|
2024
Q1 | $41.2M | Buy |
502,500
+156,800
| +45% | +$6.98M | 0.02% | 389 |
|
|
2023
Q4 | $6.43M | Sell |
345,700
-162,300
| -32% | -$2.12M | ﹤0.01% | 1372 |
|
|
2023
Q3 | $5.62M | Sell |
508,000
-101,500
| -17% | -$1.45M | ﹤0.01% | 1261 |
|
|
2023
Q2 | $9.88M | Buy |
609,500
+117,300
| +24% | +$2.46M | 0.01% | 898 |
|
|
2023
Q1 | $8.2M | Buy |
492,200
+306,800
| +165% | +$3.17M | 0.01% | 999 |
|
|
2022
Q4 | $1.74M | Buy |
185,400
+137,200
| +285% | +$612K | ﹤0.01% | 1979 |
|
|
2022
Q3 | $131K | Sell |
48,200
-81,700
| -63% | -$268K | ﹤0.01% | 5161 |
|
|
2022
Q2 | $375K | Buy |
129,900
+111,800
| +618% | +$277K | ﹤0.01% | 3818 |
|
|
2022
Q1 | $54K | Sell |
18,100
-39,400
| -69% | -$141K | ﹤0.01% | 7032 |
|
|
2021
Q4 | $264K | Sell |
57,500
-86,200
| -60% | -$483K | ﹤0.01% | 4760 |
|
|
2021
Q3 | $909K | Buy |
143,700
+4,000
| +3% | +$24.7K | ﹤0.01% | 3207 |
|
|
2021
Q2 | $836K | Buy |
139,700
+137,778
| +7,168% | +$818K | ﹤0.01% | 3390 |
|
|
2021
Q1 | $1.22M | Buy |
1,922
+569
| +42% | +$4K | ﹤0.01% | 2173 |
|
|
2020
Q4 | $761K | Sell |
1,353
-764
| -36% | -$4.63K | ﹤0.01% | 2900 |
|
|
2020
Q3 | $1.23M | Sell |
2,117
-231
| -10% | -$1.59K | ﹤0.01% | 1997 |
|
|
2020
Q2 | $1.69M | Buy |
2,348
+128
| +6% | +$850 | ﹤0.01% | 1645 |
|
|
2020
Q1 | $1.04M | Buy |
2,220
+910
| +69% | +$5.59K | ﹤0.01% | 1849 |
|
|
2019
Q4 | $1.05M | Buy |
1,310
+867
| +196% | +$6.32K | ﹤0.01% | 2053 |
|
|
2019
Q3 | $304K | Sell |
443
-45
| -9% | -$334 | ﹤0.01% | 3154 |
|
|
2019
Q2 | $405K | Sell |
488
-1,985
| -80% | -$17K | ﹤0.01% | 2776 |
|
|
2019
Q1 | $2.46M | Buy |
2,473
+1,687
| +215% | +$14.1K | 0.01% | 1191 |
|
|
2018
Q4 | $601K | Sell |
786
-862
| -52% | -$10.3K | ﹤0.01% | 2059 |
|
|
2018
Q3 | $2.87M | Buy |
1,648
+786
| +91% | +$9.35K | 0.01% | 965 |
|
|
2018
Q2 | $818K | Buy |
862
+704
| +446% | +$4.68K | ﹤0.01% | 1973 |
|
|
2018
Q1 | $3K | Buy |
+158
| New | +$874 | ﹤0.01% | 5067 |
|
Other funds holding VKTX
VCM
VPM
Simplex Trading's VKTX Position: Q4 2025 in Review
Simplex Trading sold out of Viking Therapeutics (VKTX) in Q4 2025, closing a stake of 33,354 shares — an estimated $1.18M sold.
Simplex Trading first reported a position in VKTX in Q1 2018 and held it in 20 quarters. The position peaked at $4.82M in Q1 2023. 424 funds tracked by Wall St. Rank hold VKTX as of Q4 2025.
- Simplex Trading reported no remaining Viking Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 33,354 Viking Therapeutics shares in Q4 2025, an estimated $1.18M.
- Simplex Trading first reported a position in Viking Therapeutics in Q1 2018 and held it in 20 quarters.
- Simplex Trading's Viking Therapeutics position peaked at $4.82M in Q1 2023.
- 424 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.